Use of il-12 to increase survival
AssigneeNeumedicines, Inc.
InventorLena A. Basile
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for increasing survival in a subject, and/or preserving bone marrow function, and/or promoting hematopoietic recovery or restoration. The methods include administering a dose of IL-12 to the subject following an acute exposure to non-therapeutic whole body ionizing radiation. Formulations and kits are also provided.
Claims19
1-27. (canceled)
A kit for increasing survival in a subject, and/or preserving bone marrow function, and/or promoting hematopoietic recovery or restoration following non-therapeutic acute exposure to whole body ionizing radiation,
- the kit comprising one or more formulations of a therapeutically effective dose of Interleukin-12 (IL-12).
The kit of claim 38, wherein the rhIL-12 is HemaMax™.
Dependencies are inferred from the claim text.